Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
J Clin Aesthet Dermatol ; 9(6): 56-7, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27386053

ABSTRACT

BACKGROUND: Nodular scleroderma, also known as keloidal scleroderma, is a rare variant of systemic sclerosis. PURPOSE: The clinical features, pathologic findings and postulated pathogenesis of nodular scleroderma are discussed. METHODS: A woman with previously undiagnosed systemic sclerosis who presented with nodular scleroderma is described. Using the PubMed database, a literature search was performed on keloidal scleroderma, nodular scleroderma, and systemic sclerosis. RESULTS: Nodular scleroderma is characterized by firm plaques or nodules, which can mimic a keloid, that are typically located on the anterior orposterior upper trunk and the arms; they show pathologic changes of scleroderma, keloid, or hypertrophic scar. Akeloidal response of inflamed skin that is involved in an active fibrotic process inherent to systemic sclerosis, in individuals who are genetically predisposed to keloid formation, is the hypothesized pathogenesis. CONCLUSION: Nodular scleroderma is rare. The authors' patient presented with diarrhea, dysphagia, fatigue, Raynaud's phenomenon, shortness of breath, and annular keloidal plaques of morphea whose biopsy showed features of hypertrophic scar; additional studies confirmed the diagnosis of the nodular scleroderma variant of systemic sclerosis. The possibility of systemic sclerosis should be entertained in patients who present with nodularor keloidal plaques that morphologically resemble morphea and have histologic findings of a scar or a keloid-especially if there are associated symptoms suggestive for systemic sclerosis.

2.
J Drugs Dermatol ; 15(6): 670-4, 2016 Jun 01.
Article in English | MEDLINE | ID: mdl-27272072

ABSTRACT

INTRODUCTION: Although hormonal contraceptives may help acne or worsen it, there is limited evidence on the effects of many commonly prescribed agents. The present study evaluates patient-reported effect on acne from 2147 patients who were utilizing a hormonal contraceptive at the time of their initial consultation for acne.
METHODS: At the time of initial consultation for acne, each of 2147 consecutive patients using hormonal contraception provided her assessment of how her contraceptive had affected her acne. The Kruskal-Wallis test and logistic regression analysis were used to compare patient-reported outcomes by contraceptive type.
RESULTS: Depot injections, subdermal implants, and hormonal intrauterine devices worsened acne on average, and were inferior to the vaginal ring and combined oral contraceptives (COCs; P ≤ .001 for all pairwise comparisons), which improved acne on average. Within COC categories, a hierarchy emerged based on the progestin component, where drospirenone (most helpful) > norgestimate and desogestrel > levonorgestrel and norethindrone (P ≤ .035 for all pairwise comparisons). The presence of triphasic progestin dosage in COCs had a positive effect (P = .005), while variation in estrogen dose did not have a significant effect (P = .880).
CONCLUSIONS: Different hormonal contraceptives have significantly varied effects on acne, including among types of COC.

J Drugs Dermatol. 2016;15(6):670-674.


Subject(s)
Acne Vulgaris/diagnosis , Acne Vulgaris/drug therapy , Contraceptive Devices, Female , Contraceptives, Oral, Combined/administration & dosage , Contraceptives, Oral, Combined/classification , Drug Implants/administration & dosage , Acne Vulgaris/chemically induced , Adolescent , Adult , Contraceptive Devices, Female/adverse effects , Contraceptive Devices, Female/classification , Contraceptives, Oral, Combined/adverse effects , Contraceptives, Oral, Hormonal/administration & dosage , Contraceptives, Oral, Hormonal/adverse effects , Contraceptives, Oral, Hormonal/classification , Delayed-Action Preparations , Drug Implants/adverse effects , Drug Implants/classification , Female , Humans , Middle Aged , Retrospective Studies , Young Adult
3.
Dermatol Online J ; 18(7): 9, 2012 Jul 15.
Article in English | MEDLINE | ID: mdl-22863631

ABSTRACT

A poroma is a benign epithelial neoplasm that most commonly presents as a solitary papule on the palm or sole. We report the case of a 25-year-old male, with a history of acute myelogenous leukemia, who developed multiple poromas on the feet. Poromatosis - the occurrence of multiple poromas - has been described in six adults and one child; it appears to be more prevalent in patients with a history of lymphoproliferative disorder or radiation exposure.


Subject(s)
Foot Diseases/diagnosis , Neoplasms, Multiple Primary/diagnosis , Neoplasms, Second Primary/diagnosis , Poroma/diagnosis , Sweat Gland Neoplasms/diagnosis , Adult , Bone Marrow Transplantation/adverse effects , Foot Diseases/etiology , Foot Diseases/pathology , Humans , Leukemia, Myeloid, Acute/complications , Male , Neoplasms, Multiple Primary/etiology , Neoplasms, Multiple Primary/pathology , Neoplasms, Second Primary/etiology , Neoplasms, Second Primary/pathology , Poroma/etiology , Poroma/pathology , Sweat Gland Neoplasms/etiology , Sweat Gland Neoplasms/pathology
4.
Dermatol Online J ; 18(4): 3, 2012 Apr 15.
Article in English | MEDLINE | ID: mdl-22559018

ABSTRACT

The term "signet ring" is used to describe a cell with an eccentric nucleus that is compressed to the periphery of the cell by a large cytoplasmic vacuole or by a substance accumulated within the cytoplasm. In pathology, these cells have been traditionally associated with adenocarcinomas. We describe two cases of cutaneous tumors that contained signet ring-like cells. Because of the morphology of the cells and the fact that one patient had a past history of lung cancer, the possibility of metastatic adenocarcinoma was considered. Upon further investigation, the tumors proved to be a primary cutaneous squamous cell carcinoma and a basal cell carcinoma; surgical management was curative. Because signet ring changes may pose a diagnostic challenge, we review the various benign and malignant cutaneous lesions that have been reported to contain signet ring cells and we explore the possible causative mechanisms of this phenomenon.


Subject(s)
Carcinoma, Basal Cell/pathology , Carcinoma, Signet Ring Cell/pathology , Carcinoma, Squamous Cell/pathology , Skin Neoplasms/pathology , Aged , Aged, 80 and over , Carcinoma, Basal Cell/surgery , Carcinoma, Squamous Cell/surgery , Diagnosis, Differential , Female , Humans , Male , Skin Neoplasms/surgery
5.
Dermatol Online J ; 16(12): 4, 2010 Dec 15.
Article in English | MEDLINE | ID: mdl-21199630

ABSTRACT

A 71-year-old woman presented with exquisitely tender mucosal erosions, a diffuse polymorphous eruption, and night sweats. Workup revealed multiple myeloma with a monoclonal IgG-kappa paraprotein in the serum. Her severe oral involvement was suggestive of paraneoplastic pemphigus, but direct and indirect immunofluorescence tests were negative. A skin biopsy showed spongiosis and a sparse perivascular lymphocytic infiltrate, with occasional CD8-positive lymphocytes in the epidermis. Her lesions improved with intravenous immune globulin. Immunohistochemical staining on the formalin-fixed biopsy specimen was strongly positive for IgG and IgG-kappa in an epidermal "chicken-wire" pattern, but negative for IgG-lambda. Her pulmonary tissue stained negative for IgG-kappa, suggesting clinical relevance of the myeloma paraprotein in her epidermis. To our knowledge, this is the first report of a multiple myeloma patient with such an eruption.


Subject(s)
Mucositis/etiology , Multiple Myeloma/diagnosis , Paraneoplastic Syndromes/etiology , Skin Diseases, Papulosquamous/etiology , Aged , Diagnosis, Differential , Epidermis/chemistry , Epidermis/pathology , Fatal Outcome , Female , Fluorescent Antibody Technique, Indirect , Humans , Immunoglobulin kappa-Chains/analysis , Immunoglobulins, Intravenous/therapeutic use , Mucositis/diagnosis , Mucositis/pathology , Mucositis/therapy , Multiple Myeloma/complications , Multiple Myeloma/therapy , Myeloma Proteins/analysis , Paraneoplastic Syndromes/diagnosis , Paraneoplastic Syndromes/pathology , Paraneoplastic Syndromes/therapy , Pemphigus/diagnosis , Pruritus/etiology , Pruritus/pathology , Pruritus/therapy , Pulmonary Alveolar Proteinosis/etiology , Skin Diseases, Papulosquamous/diagnosis , Skin Diseases, Papulosquamous/pathology , Skin Diseases, Papulosquamous/therapy , Sweating , Weight Loss
6.
Dermatol Online J ; 13(2): 21, 2007 May 01.
Article in English | MEDLINE | ID: mdl-17498440

ABSTRACT

Basal cell nevus syndrome is an autosomal dominant disorder characterized by multiple basal cell carcinomas, along with numerous other documented clinical features. Acrochordons (or skin tags) are common benign neoplasms that are appropriately left untreated in most patients. We describe two patients with known BCNS who were found to have multiple BCCs that clinically resembled acrochordons. Our findings support the biopsy of acrochordon-like growths in patients with basal cell nevus syndrome to rule out basal cell carcinoma.


Subject(s)
Basal Cell Nevus Syndrome/pathology , Carcinoma, Basal Cell/pathology , Cell Transformation, Neoplastic/pathology , Skin Neoplasms/pathology , Basal Cell Nevus Syndrome/surgery , Biopsy, Needle , Carcinoma, Basal Cell/surgery , Child , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Immunohistochemistry , Middle Aged , Risk Assessment , Skin Neoplasms/surgery
7.
Dermatol Surg ; 33(1): 69-72, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17214681

ABSTRACT

BACKGROUND: Basal cell carcinoma (BCC) is the most common occurring cancer in humans. No studies to date have compared the size of a patient's first and second primary BCC to determine whether we are detecting and treating second primary cancers at earlier stages of development. OBJECTIVE: The objective was to ascertain whether patients who have had a primary BCC are diagnosed and treated for subsequent BCC at an earlier clinical stage of development. METHODS AND MATERIALS: We performed a 4-year retrospective chart review of all patients presenting for Mohs micrographic surgery for two separate primary BCC. We compared the presenting clinical size of patients' first and second primary BCC. RESULTS: We found a statistically significant decrease in size of the second primary BCC when compared to the first primary BCC (p<.0001). The mean difference was 116.6 mm2 and the median difference was 28.3 mm2. CONCLUSION: Our results provide important quantitative data illustrating our effectiveness in detecting subsequent BCC at an earlier stage of development. Earlier detection of skin cancers can decrease the morbidity and chance of recurrence as well as lead to smaller scars and better cosmetic outcomes and may also allow for various treatment modalities and cost containment.


Subject(s)
Carcinoma, Basal Cell/pathology , Carcinoma, Basal Cell/surgery , Neoplasms, Second Primary/pathology , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Early Diagnosis , Female , Follow-Up Studies , Humans , Male , Middle Aged , Mohs Surgery , Neoplasms, Second Primary/surgery , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...